Vai al contenuto principale della pagina
| Autore: |
Dasí Francisco
|
| Titolo: |
Rare Respiratory Diseases: A Personal and a Public Health Problem
|
| Pubblicazione: | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica: | 1 online resource (242 p.) |
| Soggetto topico: | Medicine and Nursing |
| Pharmacology | |
| Soggetto non controllato: | active lifestyle |
| ALI culture | |
| alpha-1 antitrypsin deficiency | |
| Alpha-1 antitrypsin deficiency | |
| alpha-1-antitrypsin deficit | |
| alpha1 antitrypsin deficiency | |
| alpha1-antitrypsin deficiency | |
| antibody | |
| antioxidant therapies | |
| asthma | |
| augmentation therapy | |
| bio-resource | |
| bronchiectasis | |
| chronic obstructive pulmonary disease | |
| cilia | |
| clinical presentation | |
| cystic fibrosis | |
| diagnostics | |
| emphysema | |
| endoplasmic reticulum stress | |
| exhaled breath condensate | |
| flow cytometry | |
| gamma-glutamyl transpeptidase | |
| gene therapy | |
| glutamate-oxaloacetate transaminase | |
| glutamate-pyruvate transaminase | |
| idiopathic pulmonary fibrosis | |
| immunofluorescence | |
| infection control measure | |
| laterality defect | |
| liver disease | |
| miRNA expression | |
| Mycobacterium avium | |
| Mycobacterium intracellulare | |
| n/a | |
| nasal epithelium | |
| neonatal respiratory distress | |
| nodular bronchiectasis | |
| non-tuberculous mycobacteria | |
| orphan diseases | |
| oxidative stress | |
| PCD | |
| primary ciliary dyskinesia | |
| primary nasal epithelium | |
| pulmonary aspergillosis | |
| pulmonary exacerbation | |
| rare diseases | |
| rare pulmonary disease | |
| rare respiratory diseases | |
| reactive oxygen species | |
| reference centres | |
| replacement therapy | |
| resilience | |
| self-quarantine | |
| severity | |
| sputum | |
| standard diagnosis | |
| stress levels | |
| transient elastography | |
| Persona (resp. second.): | DasíFrancisco |
| Sommario/riassunto: | Dear Colleagues, A rare disease, also known as an orphan disease, is any disease that affects a small percentage of the population. Although definitions vary from continent to continent, according to the European Union, rare diseases are those with a prevalence of less than 1 in 2000 people. Rare diseases are, in general, chronic, debilitating diseases, which in many cases threaten patients' lives. It is estimated that 1-2 million people in the European Union are affected by a rare respiratory disease, which is a public health problem. Due to the low prevalence and severity of many of these diseases, whose symptoms often initially manifest in childhood, combined efforts are needed to improve our knowledge of the pathophysiology of these diseases that will lead to the development of new, more effective treatments. Therefore, since rare respiratory diseases represent an important field in medicine, we propose this Special Issue to promote the dissemination of the latest advances in basic and clinical research in these diseases. Prof. Dr. Francisco Dasí Guest Editor |
| Altri titoli varianti: | Rare Respiratory Diseases |
| Titolo autorizzato: | Rare Respiratory Diseases: A Personal and a Public Health Problem ![]() |
| Formato: | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910566479403321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |